US Stock MarketDetailed Quotes

DVA DaVita

Watchlist
  • 150.780
  • +0.370+0.25%
Close Mar 25 16:00 ET
  • 149.450
  • -1.330-0.88%
Post 18:54 ET
12.06BMarket Cap14.05P/E (TTM)

About DaVita Company

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Company Profile

SymbolDVA
Company NameDaVita
Listing DateOct 30, 1995
Issue Price15.50
Founded1994
CEOMr. Javier J. Rodriguez
MarketNYSE
Employees76000
Fiscal Year Ends12-31
Address2000 16th Street
CityDenver
ProvinceColorado
CountryUnited States of America
Zip Code80202-7198
Phone1-720-631-2100

Company Executives

  • Name
  • Position
  • Salary
  • Javier J. Rodriguez
  • Director and Chief Executive Officer
  • 6.71M
  • James O. Hearty
  • Chief Compliance Officer
  • 2.73M
  • Joel Ackerman
  • Chief Financial Officer and Treasurer
  • 6.87M
  • David P. Maughan
  • Chief Operating Officer, DaVita Kidney Care
  • --
  • Michael David Staffieri
  • Chief Operating Officer Emeritus
  • 10.42M
  • Kathleen Alyce Waters
  • Chief Legal and Public Affairs Officer
  • 5.61M
  • Christopher M. Berry
  • Chief Accounting Officer
  • --
  • Pamela M. Arway
  • Chairman of the Board
  • 497.46K
  • Dennis W. Pullin
  • Director
  • --
  • Phyllis R. Yale
  • Independent Director
  • 374.96K
  • Wendy L. Schoppert
  • Independent Director
  • 106.86K
  • Charles G. Berg
  • Independent Director
  • 322.46K
  • Adam H. Schechter
  • Independent Director
  • 334.96K
  • Barbara J. Desoer
  • Independent Director
  • 384.96K
  • Gregory J Moore
  • Independent Director
  • 355.89K
  • Jason M. Hollar
  • Independent Director
  • 364.96K

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More